+$/) 3$*( % : 3$&.$*( 5$7( +$/) 3$*( &2/25 3$&.$*( 5$7( 5V 5V <28 *(7 <28 *(7 z +DOI 3DJH % : LQ 7KH 0D]DGD 3KDUPD *XLGH LVVXH z +DOI 3DJH &RORU LQ 7KH 0D]DGD 3KDUPD *XLGH LVVXH z +DOI 3DJH % : LQ $OO ,QGLD )RUPXODWRUV 'LUHFWRU\ z +DOI 3DJH &RORU LQ $OO ,QGLD )RUPXODWRUV 'LUHFWRU\ z +DOI 3DJH % : LQ $OO ,QGLD $3, %XON 'UXJV 'LUHFWRU\ z +DOI 3DJH &RORU LQ $OO ,QGLD $3, %XON 'UXJV 'LUHFWRU\ $/62 *(7 +$/) 3$*( &2/25 ,1 63(&,$/ 6833/(0(17 :(67 =21( 6287+ =21( z 3+$50$ /,9( (;32 080%$, z ,1',$ /$% (;32 $1$/<7,&$ $1$&21 ,1',$ 080%$, z +3&, 080%$, z 3+$50$ /$% (;32 080%$, z 3+$50$ /$% (;32 *2$ z ,3+(; +<'(5$%$' z $6,$ /$%(; %$1*$/25( z 3+$50$& 6287+ &+(11$, z 3+$50$ 352 3$&. (;32 +<'(5$%$' z ,1',$ /$% (;32 $1$/<7,&$ $1$&21 ,1',$ +<'(5$%$' *8-$5$7 =21( 1257+ =21( z $6,$ /$%(; $+0('$%$' z ,1'8675,$/ (;32 $1.(/(6+:$5 z ,1'8675,$/ (;32 '$+(- z &3+, z 3+$50$ /$% (;32 ,1'25( )8// 3$*( % : 3$&.$*( 5$7( )8// 3$*( &2/25 3$&.$*( 5$7( 5V 5V <28 *(7 <28 *(7 z )XOO 3DJH % : LQ 7KH 0D]DGD 3KDUPD *XLGH LVVXH z )XOO 3DJH &RORU LQ 7KH 0D]DGD 3KDUPD *XLGH LVVXH z )XOO 3DJH % : LQ $OO ,QGLD )RUPXODWRUV 'LUHFWRU\ z )XOO 3DJH &RORU LQ $OO ,QGLD )RUPXODWRUV 'LUHFWRU\ z )XOO 3DJH % : LQ $OO ,QGLD $3, %XON 'UXJV 'LUHFWRU\ z )XOO 3DJH &RORU LQ $OO ,QGLD $3, %XON 'UXJV 'LUHFWRU\ $/62 *(7 +$/) 3$*( &2/25 ,1 63(&,$/ 6833/(0(17 104 :(67 =21( 6287+ =21( z 3+$50$ /,9( (;32 080%$, z ,1',$ /$% (;32 $1$/<7,&$ $1$&21 ,1',$ 080%$, z +3&, 080%$, z 3+$50$ /$% (;32 080%$, z 3+$50$ /$% (;32 *2$ z ,3+(; +<'(5$%$' z $6,$ /$%(; %$1*$/25( z 3+$50$& 6287+ &+(11$, z 3+$50$ 352 3$&. (;32 +<'(5$%$' z ,1',$ /$% (;32 $1$/<7,&$ $1$&21 ,1',$ +<'(5$%$' *8-$5$7 =21( 1257+ =21( z $6,$ /$%(; $+0('$%$' z ,1'8675,$/ (;32 $1.(/(6+:$5 z ,1'8675,$/ (;32 '$+(- z &3+, z 3+$50$ /$% (;32 ,1'25( THE MAZADA PHARMA GUIDE